Vermont’s governor has signed S. 48, a law that would revise the state’s current pharmaceutical marketing disclosure requirements. The new statute expands the application of Vermont’s current requirement that pharmaceutical manufacturers annually disclose certain expenditures made in connection to interactions with Vermont health care professionals. Under the revised law, the disclosure requirement now also applies to medical device companies. Further, the revised law adds a ban on certain items and expenditures that was not included in the previous version. Notably, this gift ban may go into effect as early as July 1, 2009. The following summarizes the revised Vermont law, including key dates for compliance.